Chemosensing in enteroendocrine cells: mechanisms and therapeutic opportunities

Purpose of review Enteroendocrine cells (EECs) are scattered chemosensory cells in the intestinal epithelium that release hormones with a wide range of actions on intestinal function, food intake and glucose homeostasis. The mechanisms by which gut hormones are secreted postprandially, or altered by antidiabetic agents and surgical interventions are of considerable interest for future therapeutic development. Recent findings EECs are electrically excitable and express a repertoire of G-protein coupled receptors that sense nutrient and nonnutrient stimuli, coupled to intracellular Ca2+ and cyclic adenosine monophosphate. Our knowledge of EEC function, previously developed using mouse models, has recently been extended to human cells. Gut hormone release in humans is enhanced by bariatric surgery, as well as by some antidiabetic agents including sodium-coupled glucose transporter inhibitors and metformin. EECs are important potential therapeutic targets. A better understanding of their chemosensory mechanisms will enhance the development of new therapeutic strategies to treat metabolic and gastrointestinal diseases.

Automated summary

The review discusses the role of enteroendocrine cells in intestinal function, food intake, and glucose homeostasis, as well as the importance of understanding their chemosensory mechanisms for therapeutic development. Recent research has shown similarities in the function and mechanisms of EECs between human cells and mouse models, providing new strategies for treating metabolic and gastrointestinal diseases.